Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

[1]  Hui Wang,et al.  CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway , 2020, Journal of cellular physiology.

[2]  A. Gure,et al.  A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer , 2020, Journal of Cancer.

[3]  R. Hass,et al.  Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation , 2019, Cancers.

[4]  Wei Xue,et al.  CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition , 2019, Cell Communication and Signaling.

[5]  Saugata Hazra,et al.  The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective , 2019, Journal of cellular physiology.

[6]  T. Tan,et al.  The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells , 2019, Communications Biology.

[7]  R. G. Austin,et al.  E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms , 2019, Molecular Cancer Research.

[8]  T. Brabletz,et al.  Non-redundant functions of EMT transcription factors , 2019, Nature Cell Biology.

[9]  J. Thiery,et al.  Mesenchymal–epithelial transition in development and reprogramming , 2019, Nature Cell Biology.

[10]  M. Todaro,et al.  Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells , 2018, BMC Cancer.

[11]  Q. Tao,et al.  OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma , 2018, Theranostics.

[12]  H. Kalofonos,et al.  ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance. , 2018, Cancer genomics & proteomics.

[13]  G. Berx,et al.  Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity. , 2017, Trends in genetics : TIG.

[14]  Q. Wang,et al.  Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. , 2017, International journal of oncology.

[15]  S. Frisch,et al.  Roles of Grainyhead-like transcription factors in cancer , 2017, Oncogene.

[16]  J. Thiery,et al.  New insights into the role of EMT in tumor immune escape , 2017, Molecular oncology.

[17]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[18]  R. Weinberg,et al.  Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. , 2017, Cancer research.

[19]  M. Colombo,et al.  Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. , 2016, Cell reports.

[20]  G. Neufeld,et al.  Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth , 2016, Oncotarget.

[21]  C. Ihm,et al.  Exosome cargo reflects TGF-β1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells. , 2016, Biochemical and biophysical research communications.

[22]  C. Cho,et al.  Mechanisms of drug resistance in colon cancer and its therapeutic strategies. , 2016, World journal of gastroenterology.

[23]  M. Zöller,et al.  CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells , 2016, Oncotarget.

[24]  M. Garcia-Blanco,et al.  Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2 , 2016, Molecular and Cellular Biology.

[25]  Yan Yan,et al.  High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer , 2016, OncoTargets and therapy.

[26]  S. Casimiro,et al.  Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer. , 2016, Clinical colorectal cancer.

[27]  E. Ruíz-García,et al.  Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy , 2016, Cancer Medicine.

[28]  Zhe-Xiong Lian,et al.  Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma , 2016, Oncotarget.

[29]  M. Cristofanilli,et al.  Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas , 2016, Breast Cancer Research.

[30]  Ming Tan,et al.  GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification , 2016, Scientific Reports.

[31]  Wei Zhang,et al.  Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma , 2016, Journal of experimental & clinical cancer research : CR.

[32]  Chengwu Tang,et al.  Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition , 2015, Cancer Cell International.

[33]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[34]  R. Weinberg,et al.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. , 2015, Trends in cell biology.

[35]  Jaime Rodriguez-Canales,et al.  A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.

[36]  W. Woodward,et al.  Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells , 2015, PloS one.

[37]  M. Tang,et al.  Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation , 2015, Oncotarget.

[38]  Zhiqing Liang,et al.  CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition , 2015, Oncotarget.

[39]  M. Chilosi,et al.  Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells , 2015, British Journal of Cancer.

[40]  Yong-sheng Xiao,et al.  Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway. , 2015, International journal of oncology.

[41]  Lu Gao,et al.  Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. , 2014, Cancer letters.

[42]  B. Bonavida,et al.  Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention , 2014, Journal of experimental & clinical cancer research : CR.

[43]  T. Oskarsson,et al.  Metastatic stem cells: sources, niches, and vital pathways. , 2014, Cell stem cell.

[44]  T. Ji,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[45]  S. Takao,et al.  CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis , 2014, Molecular Cancer.

[46]  Yu-mei Feng,et al.  Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling , 2013, British Journal of Cancer.

[47]  Gina Lee,et al.  IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer , 2013, Journal of experimental & clinical cancer research : CR.

[48]  Richard C. McEachin,et al.  Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer , 2013, PloS one.

[49]  J. Schlom,et al.  Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine , 2013, Oncotarget.

[50]  Sejal Desai,et al.  Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells. , 2013, Cellular signalling.

[51]  R. Weinberg,et al.  An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. , 2013, Cancer cell.

[52]  Qi Zhang,et al.  Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. , 2013, Carcinogenesis.

[53]  T. Tan,et al.  Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. , 2013, Cancer research.

[54]  S. Barsky,et al.  The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism , 2013, Oncotarget.

[55]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[56]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[57]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[58]  P. Hoodless,et al.  Co-ordinating Notch, BMP, and TGF-β signaling during heart valve development , 2012, Cellular and Molecular Life Sciences.

[59]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[60]  Stephen T. C. Wong,et al.  Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. , 2012, Cancer research.

[61]  Ling Xia,et al.  Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells , 2012, Cancer medicine.

[62]  Alan Wells,et al.  Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases , 2012, Cancer Microenvironment.

[63]  J. Campisi,et al.  Epithelial-Mesenchymal Transition Induced by Senescent Fibroblasts , 2012, Cancer Microenvironment.

[64]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[65]  R. Schwendener,et al.  Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors , 2012, BMC Cancer.

[66]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[67]  Richard O Hynes,et al.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.

[68]  C. Dai,et al.  Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation , 2011, Molecular Cancer Research.

[69]  Marianne D. Castillo,et al.  IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. , 2011, Cancer research.

[70]  R. Weinberg,et al.  Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells? , 2011, International journal of cancer.

[71]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[72]  Michael J. Emanuele,et al.  Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate , 2011, Proceedings of the National Academy of Sciences.

[73]  Jiannis Ragoussis,et al.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization , 2011, Nature Medicine.

[74]  Y. Kawakami,et al.  The mechanisms of cancer immunoescape and development of overcoming strategies , 2011, International journal of hematology.

[75]  Sendurai A Mani,et al.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression , 2011, Breast Cancer Research.

[76]  E. Giannoni,et al.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. , 2010, Cancer research.

[77]  Zhiwei Wang,et al.  Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells , 2010, PloS one.

[78]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[79]  M. Herlyn,et al.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. , 2010, Cancer research.

[80]  Y. Bevelacqua,et al.  The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. , 2010, Genes & cancer.

[81]  B. Zhou,et al.  Snail , 2010, Encyclopedia of Evolutionary Psychological Science.

[82]  C. Iacobuzio-Donahue,et al.  Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.

[83]  Jeffrey E. Green,et al.  VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. , 2010, Experimental cell research.

[84]  Bjørn Tore Gjertsen,et al.  Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival , 2009, Proceedings of the National Academy of Sciences.

[85]  I. Sánchez-García.  The crossroads of oncogenesis and metastasis. , 2009, The New England journal of medicine.

[86]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[87]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[88]  F. Vesuna,et al.  Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.

[89]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[90]  B. Evers,et al.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. , 2009, Cancer cell.

[91]  Zhiwei Wang,et al.  Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. , 2009, Cancer research.

[92]  Yutaka Kawakami,et al.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. , 2009, Cancer cell.

[93]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[94]  Jean-Philippe Coppé.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2009 .

[95]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[96]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[97]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[98]  A. Wells,et al.  E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas , 2008, Clinical & Experimental Metastasis.

[99]  Zhiwei Wang,et al.  Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.

[100]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[101]  M. Waltham,et al.  Epithelial mesenchymal transition traits in human breast cancer cell lines , 2008, Clinical & Experimental Metastasis.

[102]  M. Holderfield,et al.  Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. , 2008, Circulation research.

[103]  Douglas S. Darling,et al.  Zeb1 links epithelial-mesenchymal transition and cellular senescence , 2008, Development.

[104]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[105]  Dalin He,et al.  Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1α , 2007 .

[106]  R. Foisner,et al.  The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.

[107]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[108]  R. Shah,et al.  E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. , 2006, The Journal of urology.

[109]  Sheung Tat Fan,et al.  Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition , 2006, Clinical Cancer Research.

[110]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[111]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[112]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[113]  Robert D Cardiff,et al.  The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.

[114]  D. Tarin,et al.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.

[115]  M. Klymkowsky.  β-catenin and its regulatory network , 2005 .

[116]  A. Mercurio,et al.  The epithelial-mesenchymal tansition (EMT) and colorectal cancer progression , 2005, Cancer biology & therapy.

[117]  D. Solter,et al.  Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast , 2004, Development.

[118]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[119]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[120]  I. Fabregat,et al.  Snail blocks the cell cycle and confers resistance to cell death. , 2004, Genes & development.

[121]  H. Beug,et al.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis , 2003, Nature Reviews Molecular Cell Biology.

[122]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[123]  V. Paradis,et al.  Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. , 2001, European journal of cancer.

[124]  Michael Platten,et al.  Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β , 2001, Journal of Neuro-Oncology.

[125]  V. Kosma,et al.  Reduced expression of α-catenin, β-catenin, and γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer , 2001, Journal of clinical pathology.

[126]  K. Sugimachi,et al.  Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance , 2000 .

[127]  T. Koga,et al.  Expression of E-cadherin and beta-catenin in human non-small cell lung cancer: Clinical significance and prognosis , 2000 .

[128]  J. Jónasson,et al.  The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. , 1998, Cytokine.

[129]  L. Chodosh,et al.  Precocious Mammary Gland Development in P-Cadherin–deficient Mice , 1997, The Journal of cell biology.

[130]  S. Barsky,et al.  Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. , 1996, The American journal of surgical pathology.

[131]  A. Cano,et al.  Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. , 1993, Journal of cell science.

[132]  M. Perryman,et al.  An epithelial scatter factor released by embryo fibroblasts. , 1985, Journal of cell science.

[133]  E. Hay,et al.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.

[134]  W. Fontes,et al.  The multifaceted role of extracellular vesicles in metastasis: Priming the soil for seeding , 2017, International journal of cancer.

[135]  X. Ren,et al.  IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). , 2016, International journal of oncology.

[136]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[137]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2016 .

[138]  P. Yongvanit,et al.  Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[139]  Y. Tokura,et al.  Epithelial-mesenchymal transition in the skin. , 2011, Journal of dermatological science.

[140]  David Cameron,et al.  A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer , 2009, Nature Medicine.

[141]  L. Ellis,et al.  Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. , 2006, Cancer research.

[142]  Jeremy J. W. Chen,et al.  The role of interleukin-8 in cancer cells and microenvironment interaction. , 2005, Frontiers in bioscience : a journal and virtual library.

[143]  W. Jiang,et al.  Cell adhesion molecules and adhesion abnormalities in prostate cancer. , 2002, Critical reviews in oncology/hematology.

[144]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.